Over the last two decades, nanotechnology has become one of the most dynamically evolving field of research. Various types of nanoparticles are widely exploited to extend our understanding of biological interactions at the molecular level. They are actively engaged in the biomedical research for imaging, biosensing, drug delivery and/or concurrent therapy. Recent progress on this …
Category Archive: Berthiaume Institute for Precision Health
Nov 28
Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy
Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …
May 14
TechConnect 2018 an SBIR/STTR Haven
TechConnect #techconnect keeps getting better every year! Anaheim was a great location, with a good mix of entrepreneurs and investors! Looking forward to the next one in Boston in May 2019. I chaired a very engaging panel of experts who elaborated on the biggest problem facing the industrial production of uniform nanoparticles. I showcased Notre …
May 04
College of Science Joint Annual Meeting (CoS-JAM) Poster Presentation (May 4, 2018)
The poster presented by the undergraduate researchers (Margo Waters and Veronica Kalwatjys), explaining their work on a rationally designed, modular antimicrobial nanoparticle system was well received at COS-JAM 2018. Margo worked on the synthesis of the antimicrobial nanoparticles. Veronica has started testing the antimicrobial properties of these nanoparticles under the direction of Dr. Juliane Hopf. …
May 01
CD133+ Cancer Stem Cells Role in Metastasis
Excited for the 2nd publication this year through collaborative efforts with Harper Cancer Research Institute’s Karen Dahl (Title: CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche). I did the 3D confocal imaging that showed CD133+ ovarian cancer cells clearly penetrate the basal epithelial cells, pointing to metastatic potential of stem cell like cancer cells. Looking …
Apr 01
MRS 2018 Spring Symposium,
I will be at MRS 2018 from April 1 to April 5 presenting my work on novel cancer therapeutics Title: Biocompatible, Radiotherapeutic Hafnium Oxide Nanoparticle Imaging Probes Prepared Using a Novel Templated Synthesis Abstract Control ID: # 2884959 Paper # NM05.01.05 Presentation Date: April 2, 2018 Presentation Time: 9:30 AM to 9:45 AM Location: PCC …
Mar 06
6th Annual Advanced Diagnostics and Therapeutics (AD&T) Symposium – March 6, 2018
Undergraduate Research Assistant Margo Waters (Sophomore), at her first poster presentation. Margo synthesizes the anisotropic nanoparticles being used in the ongoing study looking into the applications of antimicrobial peptides@nanoparticles as surfactants on implant materials and medical devices. The project lead is Dr. Juliane Hopf and her undergraduate mentee is Veronica Kalwatjys. The work is in collaboration …
NIH Funding Opportunities
- Notice of Informational Webinar for RFA-AI-27-018, Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) October 7, 2026Notice NOT-AI-26-004 from the NIH Guide for Grants and Contracts
- Request for Information: Timing of Submission of Prior Approval Requests for IDeA Program Post-Award Projects October 5, 2026Notice NOT-GM-26-012 from the NIH Guide for Grants and Contracts
- Accelerated Implementation of Data Management and Sharing Plan Changes for NIH Career Development (K) Awards October 5, 2026Notice NOT-OD-26-120 from the NIH Guide for Grants and Contracts
Recent Comments